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Summary
Objective: X-ray imaging of articular cartilage using anionic contrast agents has been introduced for quantiﬁcation of tissue glycosaminoglycan
(GAG) concentration. In this in vitro study we investigated diffusion and equilibrium distribution of an anionic contrast agent in human articular
cartilage and related the results to tissue composition and integrity.
Methods: Osteochondral cylinders (d¼ 4.0 mm, n¼ 24) were prepared from femoral medial condyles (FMCs, cartilage thickness 2.13
0.54 mm, mean standard deviation [SD]), and tibial medial plateaus ([TMPs]1.99 0.38 mm) of human cadaver knees. Samples were
immersed for 24 h at room temperature in 21 mM concentration of anionic contrast agent Hexabrix. The X-ray absorption maps and proﬁles
were measured before immersion, and after every 2 h of immersion using clinical peripheral quantitative computed tomography (pQCT).
Results: An increase in X-ray attenuation along cartilage depth, indicating a characteristic density proﬁle increasing from superﬁcial to deep
tissue, could be seen in pQCT images acquired without contrast agent. The complete diffusion of the contrast agent into cartilage took more
than 12 h. However, the uronic acid concentration correlated with the contrast agent concentration in femoral cartilage (r¼0.76, n¼ 12,
P¼ 0.004) as early as after 2 h of immersion, and the linear correlation was virtually unchanged during the remaining 22 h. Similarly, the
histological tissue integrity (Mankin score) correlated positively with the contrast agent concentration in tibial cartilage (r¼þ0.75,
P¼ 0.005) after 2 h of immersion. The X-ray absorption proﬁles before immersion, i.e., without the contrast agent, and after 24 h of immersion
were signiﬁcantly correlated (r¼0.76 0.34, mean SD).
Conclusions: Although the complete contrast agent diffusion into human articular cartilage in vitro took more than 12 h, signiﬁcant apparent
correlations were revealed between the spatial proteoglycan (PG) and contrast agent distributions already after 2 h of immersion. At the stage
of incomplete penetration, however, the spatial contrast agent concentration distribution cannot directly reﬂect the true PG distribution as the
Donnan equilibrium has not been reached. However, in degenerated cartilage the diffusion rate increases. Obviously, this can lead to the
reported correlation between the bulk PG content and the bulk contrast agent concentration already at the early stages of diffusion.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Mechanical properties of articular cartilage depend strongly
on the integrity of collagen network and proteoglycan (PG)
concentration1,2. In intact cartilage the water concentration
decreases and glycosaminoglycan (GAG) (and PG) con-
centration increases with depth3e6. In intact cartilage, the
ﬁxed charge density (FCD) increases with depth, or remains
constant in the deep zone3e6. Collagen concentration is
lowest in the middle zone. In terms of collagen and PGs
the solid fraction increases with depth. In osteoarthrotic car-
tilage water concentration increases particularly in the mid-
dle zone, PG concentration decreases and collagen
network becomes disrupted1,3. These degenerative*Address correspondence and reprint requests to: Dr Tuomo S.
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26changes in composition and structure make cartilage softer
and prone tomechanical damage1,7. In contrast to osteoarth-
rosis, FCD increases and water concentration decreases in
articular cartilage along ageing7. The methods capable for
non-invasive quantitative diagnostics of the determinants
of mechanical properties, e.g., tissue PG concentration,
would have signiﬁcant clinical potential.
The delayed gadolinium enhanced magnetic resonance
imaging of cartilage (dGEMRIC) serves as non-invasive
clinical means to estimate cartilage PG concentration8.
However, dGEMRIC may overestimate the GAG concentra-
tion in deep cartilage9. The recent studies have demon-
strated modest capability of dGEMRIC to predict cartilage
mechanical properties at clinical ﬁeld strengths8e16. The
contrast enhanced cartilage tomography (CECT), an X-ray
analogue to dGEMRIC, has been proposed for quantiﬁca-
tion of GAG concentration of cartilage17,18. Both iodine
and gadolinium based anionic contrast agents have been
applied in previous CECT studies17e19.
27Osteoarthritis and Cartilage Vol. 17, No. 1After chemically induced depletion of PGs an increased
penetration of negatively charged or neutral contrast agent
molecules, and a decreased penetration of positively
charged contrast agent molecules into cartilage have
been reported17,19,20. These ﬁndings are in line with the
assumption that the equilibrium distribution of negatively
charged contrast agent is inversely proportional, and posi-
tively charged contrast agent directly proportional to the
negatively charged PGs present in cartilage. However, in
our recent study, depth-dependent PG depletion was not
accurately reproduced by spatial contrast agent proﬁles, al-
though the PG depleted cartilage showed increased accu-
mulation of the contrast agent (ioxaglate)19. This ﬁnding
suggests that other factors (i.e., spatial water and collagen
content), in addition to the spatial PG concentration, may
affect the contrast agent accumulation.
Depending on the sample size and experimental geometry
various different immersion times have been applied for
contrast agent: in vivo 0.5e7 h for gadopentetate10,21e31,
and in vitro 1e24 h for gadopentetate and 1e27 h for
ioxaglate9e20,32,33. A previous study on bovine tissue reported
a continuous decrease of the T1 relaxation time in accordance
with the contrast agent accumulation into cartilage, measured
after every 30 min, and a maximum decrease was achieved
after 11 h of immersion34. In osteoarthrosis, the contrast agent
penetration into the cartilage is reported to speed up27. In vivo
intravenous administration, and ﬂuid circulations induced by
joint exercise, may speed up the penetration of contrast agent
into articular cartilage10,25,27,31,35.
In the present study, the potential of CECT was charac-
terised with human articular cartilage in vitro. In particular,
for the ﬁrst time, we investigated the diffusion behaviourFig. 1. Sample preparation. Osteochondral cylinders (d¼ 16 mm) were dril
and TMPs (n¼ 12, cartilage thickness 1.99 0.38 mm). Smaller osteocho
the pQCT measurements. Biochemical and histological analyses were c
16 mm cyliand equilibrium distribution of the anionic iodine based con-
trast agent using clinical peripheral quantitative computed
tomography (pQCT). We also related the CECT results to
tissue composition (PG and water concentration) and histo-
logical integrity (Mankin score).Materials and methods
The permission to collect human samples was granted by the Finnish Na-
tional Authority for Medicolegal Affairs (TEO 1781/32/200/01). Osteochon-
dral cylinders (diameter 16.0 mm) were drilled from femoral medial
condyles (FMCs, n¼ 12, cartilage thickness 2.13 0.54 mm, mean stan-
dard deviation [SD]) and tibial medial plateaus (TMPs, n¼ 12, cartilage thick-
ness 1.99 0.38 mm) of human cadaver knees (age 26e78 years, mean
age 55 years, n¼ 12) and stored in a freezer at 20C13. The drilling was
not found to affect cartilage integrity at the tissue under investigation. Prior
to experiment the samples were thawed and smaller osteochondral cylinders
(diameter 4.0 mm) were punched (Fig. 1). The cartilage layer in samples ex-
hibited different degenerative appearance, as revealed by semiquantitative
histological Mankin scoring36. The water concentration and uronic acid con-
centration of the samples, prepared from the tissue adjacent to the samples
of the present study, were obtained from our earlier study37. The spatial GAG
concentration proﬁles were determined using optical density measurement of
Safranin-O stained sections38.
Each sample was immersed for 24 h at room temperature in 100 ml of
phosphate buffered saline (PBS) containing 21 mM iodinated anionic con-
trast agent (Hexabrix, Mallinckrodt, St. Louis, MO, USA), and inhibitors
of proteolytic enzymes: 5 mM of ethylenediamine tetraacetic acid disodium
salt (EDTA, VWR International, Fontenay, France) and 5 mM of benzamidine
hydrochloride hydrate (SigmaeAldrich Inc., St. Louis, MO, USA). Hexabrix
is an ionic dimer containing ioxaglate meglumine and ioxaglate sodium. Both
salts disintegrate into anionic ioxaglate1. In this experiment, the diffusion
was allowed from every direction. However, the diffusion through subchon-
dral bone was found insigniﬁcant. The immersion solution was continuously
slowly agitated and sheltered from daylight, except when the samples were
transferred to pQCT imaging. Before measurements the samples were
quickly rinsed in PBS, blotted and enclosed in a polythene tube withled from human FMCs (n¼ 12, cartilage thickness 2.13 0.54 mm),
ndral cylinders were punched for the contrast agent experiment and
onducted for the cartilage extracted from the remaining part of the
nder.
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Fig. 2. Contrast agent concentration proﬁle of human tibial cartilage
after 4 h of immersion in 21 mM Hexabrix (Mankin score 2, water
concentration 69%, and uronic acid concentration 4.8 mg/mg). To
minimise the partial volume effects on the contrast agent proﬁle cal-
culations the borderline pixels at cartilage surface and cartilagee
bone interface were manually discarded.
28 T. S. Silvast et al.: Contrast agent diffusion in human cartilagea moistened Soffban plug. In the present study, absorption but no desorption
(reversed diffusion) was investigated.
The X-ray absorption maps were measured before immersion (0 h mea-
surement), and after every 2 h of immersion (up to 24 h). The measurements
were conducted using a clinical pQCT instrument (Stratec Medizintechnik
GmbH, Pforzheim, Germany). The tube voltage of 58.0 kVp, tube current of
0.175 mA, slice thickness of 2.3 mm, pixel size of 0.20 0.20 mm2, and
360 imaging projections were applied. One slice was imaged for ﬁve times
and the images were averaged to reduce the background noise. For calcu-
lation of the contrast agent concentration in cartilage X-ray absorption in con-
trast agent was calibrated using a series of phantoms with known contrast
agent concentrations ranging from 0.42 mM to 42.0 mM.
The vertical contrast agent proﬁles from cartilage surface to subchondral
bone were calculated for the middle-third of the cartilage, and the horizontal
contrast agent proﬁles were calculated as an average for the total cartilage
layer. The mean contrast agent concentration was calculated for the full
thickness cartilage. For each sample the initial spatial X-ray absorption pro-
ﬁle, i.e., the proﬁle measured before immersion, was subtracted from theFig. 3. Contrast agent diffusion into human articular cartilage. Although inv
contrast agent diffusion into deep human articular cartilage took more tha
sample was 2.5 mm (Mankin score 2, water concentration 69%, and uro
directions, however, the diffusion through subchondral bone was insign
4 h, 6 h, 12 h aproﬁles measured at other time points. To minimise situations where one
pixel could represent more than one type of tissue, i.e., the partial volume ef-
fect, the borderline pixels at cartilage surface and cartilageebone interface
were manually discarded (Fig. 2). For the same reason the sample-speciﬁc
rectangular cartilage areas were manually cropped.STATISTICAL ANALYSISThe pQCT images were analysed using Matlab (v. 6.5, MathWorks Inc.,
Natick, MA, USA). Wilcoxon signed ranks tests were conducted to investi-
gate signiﬁcance of differences in parameters determined for FMC and
TMP cartilage. Spearman correlation analysis was used to relate Mankin
scores with other parameters. Pearson correlation analysis was used to re-
late pQCT results to water concentration and uronic acid content. The corre-
lation between native cartilage X-ray absorption proﬁle and absorption proﬁle
after 24 h immersion was determined with Matlab. Other statistical analyses
were conducted using SPSS (v. 14.0, SPSS Inc., Chicago, IL, USA).Results
Diffusion of the contrast agent into human cartilage was
found to continue as long as 24 h. Typically, diffusion of
the contrast agent took at least 12 h to reach the equilibrium
state (Figs. 3 and 4). The shortest recorded time for com-
plete diffusion, in a sample with thin cartilaginous layer
(0.8 mm), was 4 h.
After 2 h of immersion, i.e., at the stage of incomplete dif-
fusion, the X-ray absorption proﬁles correlated negatively
with the GAG concentration proﬁles, determined with optical
density measurements (r¼0.83 0.19, mean SD). Sig-
niﬁcant increase in the accumulation of contrast agent in
cartilage was recorded for the remaining 22 h (Fig. 3). How-
ever, the correlation between the depth-dependent GAG
and contrast agent concentration proﬁles remained con-
stant (r¼0.81 0.19 at 24 h).
Similarly, the bulk contrast agent concentration in FMC
correlated signiﬁcantly with the uronic acid concentration
(r¼0.76, P¼ 0.004) after 2 h of immersion, and the corre-
lation remained virtually unchanged during remaining 22 h
(Table I). The highest correlation between the contrastestigated osteochondral samples were small (diameter 4.0 mm), the
n 12 h. The cartilage thickness of this particular tibial osteochondral
nic acid concentration 4.8 mg/mg). Diffusion was possible from all
iﬁcant. Time points from left to right: 0 h (before immersion), 2 h,
nd 24 h.
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Fig. 4. Vertical (perpendicular to cartilage surface) and horizontal (parallel to cartilage surface) contrast agent proﬁles as a function of immer-
sion time (2e24 h). Contrast agent diffusion took over 12 h to reach the equilibrium distribution. Left above: area deﬁned for the calculation of
vertical contrast agent proﬁle. Left below: area deﬁned for the calculation of horizontal contrast agent proﬁle. Right: vertical (above) and
horizontal (below) mean contrast agent proﬁles in human TMP cartilage (Mankin score 1e9, n¼ 12) recorded at various time points during
immersion in contrast agent.
29Osteoarthritis and Cartilage Vol. 17, No. 1agent and the uronic acid concentrations, r¼0.83, was
achieved after 4 h of immersion. The bulk contrast agent
concentration in TMP correlated signiﬁcantly with the Man-
kin score (r¼0.75, P¼ 0.005) after 2 h of immersion. The
correlation changed only slightly during the remaining 22 h
of immersion (r¼0.67, P¼ 0.018 at 24 h).
An increase of X-ray attenuation along tissue depth, i.e.,
increasing density proﬁle, could be seen in pQCT images
acquired without contrast agent (0 h, Fig. 5). The X-ray ab-
sorption proﬁles before immersion (0 h measurement) and
after 24 h of immersion were signiﬁcantly correlated
(r¼0.76 0.34, n¼ 24, meanSD). The linear correla-
tion between the absorption proﬁles was similar in TMP
(r¼0.79 0.37) and in FMC (r¼0.73 0.32).
Signiﬁcant differences in Mankin score, water concentra-
tion, and uronic acid concentration could be seen between
femoral and tibial cartilages. However, only a small differ-
ence in mean contrast agent concentrations of the tibial
and femoral cartilages could be detected with the CECT
measurements (Table II). This may imply that in addition
to PG content there may be other factors affecting contrast
agent penetration into the articular cartilage.Table
The femoral and tibial cartilages reveal differences in correlation between
tween the contrast agent concentration and Mankin score already after 2 h
values quantified from the whole cartilage
Relative absorption, 0 h Contra
FMC TMP FMC
Mankin score 0.38 0.24 þ0.02
Water content 0.23 0.40 þ0.37
Uronic acid content 0.18 0.10 0.76*
*P< 0.05 and **P< 0.01.Discussion
In the present study, contrast agent enhanced X-ray to-
mography of cartilage, CECT, was applied for human artic-
ular cartilage in vitro. For the ﬁrst time, the diffusion and
equilibrium distribution of the anionic iodine based contrast
agent was investigated in human cartilage. The CECT is
based on the use of anionic iodine based contrast agent
ioxaglate, and is analogous to the dGEMRIC. In CECT
and dGEMRIC the equilibrium distribution of negatively
charged contrast agent is assumed to follow the ﬁxed
charge distribution in cartilage. Thereby, at diffusion equilib-
rium, the contrast agent distribution is expected to reﬂect
the PG distribution in the articular cartilage25.
During the ﬁrst hours of immersion the X-ray absorption in-
creased signiﬁcantly in the superﬁcial cartilage (Fig. 4). Even
though the investigated osteochondral samples were small
(diameter¼ 4.0 mm, Fig. 1), X-ray absorption typically in-
creased in deep cartilage for further 22 h of immersion. Al-
though the present ﬁnding may not be surprising in the light
of existing literature20,39e42 immersion timesof only fewhours
havebeenused in various in vitrodGEMRICstudies9,11e13,33.I
the contrast agent concentration and uronic acid content, and be-
of immersion, although the diffusion was at its initial stage. The bulk
were used for correlation analyses
st agent content, 2 h Contrast agent content, 24 h
TMP FMC TMP
þ0.75** 0.05 þ0.67*
þ0.09 þ0.31 þ0.23
* 0.44 0.76** 0.42
pQCT-image 24h
pQCT-image 0h
surface
deep cartilage
r = -0.95 
p = 0.0000 
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Fig. 5. Representative pQCT image and contrast agent proﬁle recorded before immersion (above), and after 24 h of immersion (below) for
tibial cartilage (Mankin score 3, water concentration 76%, and uronic acid concentration 5.4 mg/mg). An increasing absorption proﬁle could
be seen in pQCT images acquired in 0 h measurement. An inverse depthwise trend in X-ray absorbtion was revealed in images acquired after
24 h of immersion. The correlation between these proﬁles was signiﬁcant (r¼0.95, P¼ 0.0000).
30 T. S. Silvast et al.: Contrast agent diffusion in human cartilageIn the present experiments the contrast agent diffusion
was possible from every direction except through the carti-
lageebone interface (Fig. 1). In this geometry, the contrast
agent penetration into deep cartilage is faster than in geom-
etry that enables diffusion only through the cartilage surface
(e.g., intra-articular injection in vivo). Further, thickness of
the cartilaginous layer affects the immersion times for full
equilibration. Thus, experimental geometry as well as vari-
able cartilage thickness can affect the measured contrast
agent proﬁles. As cartilage PG concentration increases
characteristically from superﬁcial to deep tissue, anTable II
Significant differences in Mankin score, water content, and uronic
acid content (mean SD (range)) between FMC (n ¼ 12) and
TMP (n¼ 12) cartilage groups could be seen. Without contrast
agent only a slight difference could be seen in bulk absorption of
tibial and femoral cartilages. After 24 h of immersion no significant
difference in contrast agent content could be seen between tibial
and femoral cartilages
Parameter FMC TMP
Mankin score 2.1 1.2 (0e5) 3.6 2.4* (1e9)
Water content (%) 70.0 2.6
(65.5e74.6)
73.8 6.0*
(61.6e83.5)
Uronic acid
content (mg/mg)
7.0 1.9
(3.7e10.5)
5.4 1.5*
(2.0e7.3)
Relative absorption, 0 h 1.3 0.3 1.2 0.5
Contrast agent
content, 2 h (mM)
7.3 1.7 7.8 1.6
Contrast agent content,
24 h (mM)
12.5 1.7 12.8 0.9
*P< 0.05, Wilcoxon signed ranks test.incomplete diffusion of the charged contrast agent, espe-
cially if possible only through the cartilage surface, can pro-
duce automatically a signiﬁcant association between the
depthwise PG and contrast agent concentrations. However,
in addition to the GAG concentration other factors, such as
spatial collagen concentration, may affect the penetration of
contrast agent into articular cartilage. Earlier, Kallioniemi
et al.19 showed that the GAG cleavage affected the general
level of gadopentetate penetration, but exhibited smaller
effect on the contrast agent proﬁle at equilibrium.
The association between the bulk contrast agent concen-
tration and the cartilage structural integrity, as judged by the
histological Mankin score, was signiﬁcant only in TMP car-
tilage (Table I). Further, the association between the bulk
contrast agent concentration and the tissue water concen-
tration was insigniﬁcant. Obviously, it is unrealistic to use
a bulk value of contrast agent concentration to score carti-
lage integrity1,11,43, but novel parameters describing depth-
wise contrast agent distribution could allow more sensitive
evaluation of tissue integrity.
The clinical dGEMRIC measurements are often per-
formed after only few hours of intravenous contrast agent
injection21,44. The short times may be justiﬁed as the con-
trast agent accumulation may be accelerated by the joint
exercise that can augment interstitial transport of contrast
agent via ﬂuid convection31,44,45. Further, the accumulation
of contrast agent into cartilage has been reported to be
faster after intravenous administration, as compared to in-
tra-articular administration25. This may be explained by
the contrast agent accumulation through the subchondral
bone after intravenous injection. It has been reported that
in degenerated cartilage the diffusion rate increases41. Ob-
viously, this would lead to a correlation between the PG
31Osteoarthritis and Cartilage Vol. 17, No. 1content and the contrast agent concentration already at the
early stages of diffusion. As the increase in diffusion rate
can be extensive in degenerated tissue41,46 imaging at
the early stages of diffusion may be diagnostically justiﬁed.
Furthermore, the contrast agent concentrations applied in
CECT (21 mM) are much higher than those used in dGEM-
RIC (0.5e2 mM). High contrast agent concentrations may
alter the electrochemistry and contrast agent distribution
within the tissue. Finally, in vivo diffusion occurs at body
temperature (37C) which is signiﬁcantly higher than the en-
vironment of the present study (20C).
The X-ray absorption proﬁles correlated signiﬁcantly with
the GAG concentration proﬁles already after 2 h of immer-
sion. At 2 h the diffusion was incomplete and the strong cor-
relation cannot be explained by the Donnan equilibrium. It
has been reported that, in addition to charge distribution,
the size and shape of contrast agent molecule, and the car-
tilage solid fraction play a role in contrast agent accumula-
tion41,42,47e50. Importantly, solid content and FCD
distribution in cartilage can differently affect the penetration
of different contrast agents. However, as the physical sizes
of gadopentetate-molecule (MR contrast agent) and ioxa-
glate salt molecules (CT contrast agent) are comparable,
the diffusion coefﬁcients of gadopentetate and ioxaglate
may be rather similar. Thus, increased water concentration
after damaged collagen network could increase tissue
permeability and stimulate diffusion of contrast agent into
tissue27. Furthermore, the increased diffusion rate in degen-
erated tissue may explain the present correlation between
the bulk uronic acid content and the bulk contrast agent
concentration at the early stage of diffusion.
Interestingly, the X-ray absorption proﬁles before immer-
sion (0 h) and after 24 h of immersion correlated signiﬁ-
cantly. A clear X-ray absorption proﬁle could be shown in
pQCT images taken without contrast agent (0 h, Fig. 5),
i.e., the X-ray absorption proﬁle increased from superﬁcial
to deep cartilage in native tissue. This is in agreement
with the increasing solid fraction from superﬁcial to deep
cartilage6,51. As the higher solid matrix concentration in-
duces a higher attenuation of X-rays, imaging of native tis-
sue may offer a possibility to measure relative, depth-
dependent water content non-invasively.
In the pQCT, the mean Hounsﬁeld unit (HU) of contrast
agent enhanced cartilage (n¼ 24) and native cartilage
(n¼ 24) were 460 and 15, respectively. As the HU of air sur-
rounding the sample was 1000, and the HU of subchon-
dral bone was typically >1000, the cartilage contrast was
good and the cartilaginous layer could be easily segmented
for analysis. To minimise the partial volume effect, the bor-
derline pixels at cartilage surface and cartilageebone inter-
face were manually discarded. The biochemical analyses of
cartilage composition were conducted using tissue samples
adjacent (within few millimetres) to the site of pQCT imag-
ing. Obviously, this can slightly affect the reliability of the
comparisons. The present samples were carefully selected
from a region that visually represented a uniform cartilage
area. Although possible microscopical variations in tissue
characteristics of the adjacent samples may exist, it is as-
sumed that the samples prepared from the adjacent tissue
represent adequately the sample prepared for the pQCT ex-
periment. To minimise possible cartilage degradation during
immersion in contrast agent solution inhibitors of proteolytic
enzymes were included in the solution.
As a conclusion, the complete contrast agent diffusion
into human articular cartilage was seen to take more than
12 h of immersion in vitro. Although the present ﬁndings are
not surprising in the light of existing literature, immersiontimes of only few hours have been used in various in vitro
dGEMRIC studies. In native tissue the X-ray absorption pro-
ﬁle increased from superﬁcial to deep cartilage. Signiﬁcant
linear correlation between the X-ray absorption proﬁle of
native cartilage and the contrast agent concentration proﬁle
at equilibrium state was detected. Based on the present re-
sults, more experimental and theoretical studies are needed
to investigate structural and compositional factors that con-
tribute to diffusion and equilibrium accumulation of charged
molecules in normal and degenerated cartilage. Further, the
X-ray absorption of native cartilage was detected with a clin-
ical pQCT instrument. As the X-ray absorption is related to
amount and composition of solid matrix, further studies are
warranted to characterise diagnostic potential of native
cartilage pQCT imaging.Conﬂict of interest
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